Splenic Mantle Cell Lymphoma
1 clinical trials · Condition
◉ Watch Splenic Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT02420795) | M.D. Anderson Cancer Center | 2015-11-03 |
Track Splenic Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.